

Company Profile
Sanofi-aventis Pakistan Limited was incorporated in Pakistan in 1967 as a Public Limited Company. The Company is a subsidiary of Sanofi Foreign Participations B.V., registered in Netherlands (the Parent Company). The Ultimate Parent of the Company is Sanofi S.A., France. It is engaged in the manufacturing and selling of pharmaceutical, consumer healthcare products and vaccines.
Mr.Asim Jamal | CEO |
Mr.Syed Babar Ali | Chairman |
Mr.Muhammad Yousaf | Company Secretary |
FAMCO Associates (Pvt) Ltd 8-F, Next to Hotel Faran, Nursery, Block -6, P.E.C.H.S Shahrah e Faisal Karachi
EY Ford Rhodes, Chartered Accountants
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Oct 29, 2020 | Transmission of Financial Statements for Period Ended September 30, 2020 | View PDF |
Oct 29, 2020 | Transmission of Financial Statements for Period Ended September 30, 2019 REVOKED | View PDF |
Oct 27, 2020 | Financial Results for the Period Ended September 30, 2020 | View PDF |
Aug 28, 2020 | SAPL | Sanofi-Aventis Pakistan Limited - Half year ended June 30, 2020 Financial Statements | | |
Aug 26, 2020 | Financial Results for the Six Months Ended June 30, 2020 | View PDF |
Apr 30, 2020 | Transmission of Quarterly Accounts for the Period Ended March 31, 2020 | View PDF |
Apr 29, 2020 | Financial Results for the Quarter Ended March 31, 2020 | View PDF |
Apr 28, 2020 | Transmission of Annual Report for the Year Ended December 31, 2019 | View PDF |
Mar 3, 2020 | Financial Results for the Year Ended December 31, 2019 | View PDF |
Oct 28, 2019 | Financial Results for the Quarter Ended September 30, 2019 | View PDF |
Date | Title | Document |
---|---|---|
Feb 18, 2021 | Board Meeting for the Year ended December 31, 2020 | View PDF |
Oct 16, 2020 | Board Meeting for the Period Ended September 30, 2020 | View PDF |
Aug 17, 2020 | BOARD MEETING FOR THE HALF YEAR ENDED JUNE 30, 2020 | View PDF |
May 20, 2020 | Certified Abstract of Resolutions Passed at the 52nd Annual General Meeting | View PDF |
Apr 28, 2020 | Board Meeting in Progress | View PDF |
Apr 27, 2020 | Notice of Annual General Meeting for the Year Ended December 31, 2019 | View PDF |
Apr 20, 2020 | Board Meeting for the Quarter ended March 31, 2020 | View PDF |
Feb 24, 2020 | Board Meeting for the Year ended December 31, 2019 | View PDF |
Nov 15, 2019 | Board of Directors' meeting Other than Financial results | View PDF |
Nov 14, 2019 | Board Meeting in Progress | View PDF |
Date | Title | Document |
---|---|---|
Oct 13, 2020 | Corporate Briefing Session for the year 2020 | View PDF |
Aug 17, 2020 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Jun 8, 2020 | Credit of Final Cash Dividend for the Year 2019 | View PDF |
May 20, 2020 | Election of Directors | View PDF |
May 11, 2020 | Notice for Election of Directors u/s 159(4) of the Companies Act, 2017 | View PDF |
Mar 30, 2020 | sanofi-aventis Pakistan Limited - Notice of postponement of AGM | View PDF |
Nov 13, 2019 | Corporate Briefing Session for the year 2019 | View PDF |
Oct 30, 2019 | Transmission of Financial Statements for nine months Ended September 30, 2019 | View PDF |
May 7, 2019 | Credit of Final Cash Dividend | View PDF |
Apr 24, 2019 | Change of Director | View PDF |
Financials
All numbers in thousands (000's) except EPS
2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|
Sales | 14,500,678 | 12,960,839 | 12,446,052 | 11,890,235 |
Profit after Taxation | 154,836 | 612,792 | 1,006,121 | 1,018,922 |
EPS | 16.05 | 63.54 | 104.32 | 105.65 |
Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | |
---|---|---|---|---|
Sales | 4,060,794 | 3,195,361 | 3,421,068 | 3,658,512 |
Profit after Taxation | 97,032 | (18,772) | (84,413) | 19,488 |
EPS | 10.06 | (1.95) | (8.75) | 2.02 |

Ratios
2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|
Gross Profit Margin (%) | 25.69 | 30.45 | 35.64 | 33.82 |
Net Profit Margin (%) | 1.07 | 4.73 | 8.08 | 8.57 |
EPS Growth (%) | (74.74) | (39.09) | (1.26) | 1,433.38 |
PEG | (0.69) | (0.30) | (9.48) | 0.02 |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
March 3, 2020 3:51 PM | 31/12/2019(YR) | 80% (D) | 13/05/2020 - 20/05/2020 |
March 1, 2019 1:38 PM | 31/12/2018(YR) | 300% (F) (D) | 17/04/2019 - 23/04/2019 |
March 7, 2018 3:01 PM | 31/12/2017(YR) | 450% (D) | 20/04/2018 - 26/04/2018 |
March 8, 2017 12:53 PM | 31/12/2016(YR) | 300% (D) | 19/04/2017 - 25/04/2017 |
February 25, 2016 10:14 AM | 31/12/2015(YR) | 30% (D) | 19/04/2016 - 25/04/2016 |
March 12, 2015 1:37 PM | 31/12/2014(YR) | 70% (D) | 21/04/2015 - 27/04/2015 |
February 26, 2014 2:19 PM | 31/12/2013(YR) | 100% (D) | 18/04/2014 - 25/04/2014 |
February 28, 2013 10:15 AM | 31/12/2012(YR) | 125% (F) (D) | 19/04/2013 - 25/04/2013 |
February 22, 2012 2:29 PM | 31/12/2011(YR) | 100%(F) (D) | 18/04/2012 - 24/04/2012 |
February 14, 2011 9:52 AM | 31/12/2010(YR) | 100%(F) (D) | 23/03/2011 - 29/03/2011 |